ArticleScientific reports2022
Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model.
Evan Flietner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleScientific reports2022
Evan Flietner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.